Also seen on reports as: Lipid Panel, Cholesterol Profile, Fasting Lipid Profile, FLP
What is Lipid Profile?
A Lipid Profile measures several fats (lipids) circulating in the blood, all from a single sample. The standard panel reports Total Cholesterol, LDL Cholesterol ('bad'), HDL Cholesterol ('good'), Triglycerides, and usually VLDL (calculated from triglycerides). Some Indian labs also report the Total/HDL ratio, the LDL/HDL ratio, or non-HDL cholesterol.
Cholesterol is essential — every cell in the body needs it, and the liver makes most of what the body uses. But too much LDL cholesterol in the blood, combined with low HDL and high triglycerides, increases the build-up of plaque inside artery walls — the underlying process behind most heart attacks and many strokes.
The test is run on a small blood sample drawn from a vein. NABL-accredited Indian labs report each component in milligrams per decilitre (mg/dL). Most labs still ask for an overnight fast, though newer guidelines have made non-fasting lipid testing acceptable in many situations.
Why doctors order it
Lipid Profile is a cornerstone test for cardiovascular risk assessment and is part of almost every adult routine health check in India. Most Indian guidelines (Lipid Association of India, Cardiological Society of India) recommend a baseline lipid profile in adults from at least age 30 — and earlier when there is a family history of premature heart disease, diabetes, hypertension, central obesity, or known dyslipidaemia.
Doctors order it in pre-employment medicals, antenatal panels, pre-operative work-ups, when investigating chest pain or unexplained breathlessness, and to monitor the effect of lifestyle changes or lipid-lowering medications (statins, fibrates, etc.).
Indians develop cardiovascular disease at younger ages and lower BMIs than many other populations — the so-called 'Asian-Indian phenotype' — so Indian cardiology bodies often recommend earlier screening and stricter targets than international defaults, particularly for high-risk patients.
What the result means
Each component tells a different part of the story. Total Cholesterol is a starting summary but is less informative than LDL alone. LDL is the main 'cause-of-plaque' marker; treatment targets are set against LDL more than against any other lipid number. HDL works in the opposite direction — higher HDL is generally protective, though it is no longer used as a treatment target by itself. Triglycerides reflect recent dietary intake and metabolic state; very high triglycerides also raise the risk of acute pancreatitis. VLDL is calculated from triglycerides (TG ÷ 5) and represents another plaque-promoting particle.
The Asian-Indian dyslipidaemia pattern — characteristic of many Indians — is high triglycerides, low HDL, and small dense LDL particles, often present at lower BMIs than Western reference populations. This pattern is closely linked to insulin resistance, central obesity, type-2 diabetes, and fatty liver, and travels under the umbrella of metabolic syndrome.
Treatment targets are individualised. Indian cardiology bodies (Lipid Association of India) recommend stricter LDL targets in high-risk patients (people with diabetes, prior heart attack, kidney disease, or strong family history) than international defaults — often <70 mg/dL for high-risk and <50 mg/dL for very-high-risk patients. Your doctor sets the personal target based on overall risk.
Reference range
Values in mg/dL. Lipid Association of India targets shown for high-risk situations.
- Total Cholesterol — desirable
- Below 200 mg/dL (200–239 borderline, ≥240 high)
- LDL — general population (low risk)
- Below 130 mg/dL preferred; <100 optimal
- LDL — high risk (diabetes, established heart disease)
- Below 70 mg/dL (LAI / international targets)
- LDL — very high risk
- Below 55 mg/dL or even <40 mg/dL in selected cases
- HDL — protective
- Men ≥40 mg/dL; Women ≥50 mg/dL — higher is generally better
- Triglycerides — normal
- Below 150 mg/dL (150–199 borderline, 200–499 high, ≥500 very high)
- Non-HDL Cholesterol
- Total minus HDL — should be roughly 30 mg/dL above your LDL target
LDL targets are individualised based on cardiovascular risk — a high LDL in a young, otherwise low-risk person is treated differently from the same LDL in someone with diabetes or previous heart disease. Asian-Indian dyslipidaemia (high TG, low HDL, small dense LDL) often develops at lower BMIs than Western patterns suggest.
In India
What this test means for an Indian reader
Indians display a characteristic 'Asian-Indian dyslipidemia' pattern — elevated triglycerides, low HDL, and small dense LDL particles — that emerges at lower BMIs than Western populations. Cardiovascular events also occur at younger ages, which is why Indian cardiology bodies recommend earlier and stricter lipid screening than international defaults.
Lipid Association of India risk-based LDL targets are typically stricter than US/European guidelines for high-risk patients: <70 mg/dL for high-risk, <50 mg/dL for very-high-risk individuals.
Indian guidelines & references
- Cardiological Society of India (CSI)
- Lipid Association of India (LAI)
- Association of Physicians of India (API) CVD guidelines
Common factors that affect the result
Diet, body weight, physical activity, and metabolic health are the main long-term drivers of the lipid profile. Refined-carbohydrate and sugary-drink intake raise triglycerides; saturated fat and trans-fat intake raise LDL; regular physical activity raises HDL and improves the overall profile. Central (abdominal) obesity, insulin resistance, type-2 diabetes, hypothyroidism, and chronic kidney disease all push the profile in an unfavourable direction.
Several medications affect lipids — beta-blockers and thiazide diuretics (common blood-pressure medicines) can mildly raise triglycerides; steroids raise both LDL and triglycerides; some retinoids (acne medications) raise triglycerides; oral contraceptives modestly raise both. Statins lower LDL substantially; fibrates lower triglycerides; ezetimibe lowers LDL by reducing dietary cholesterol absorption.
Recent meals matter — particularly for triglycerides. A non-fasting sample can show triglycerides 30–50 mg/dL higher than the fasting equivalent. Total cholesterol, LDL, and HDL are less affected by recent meals. Acute illness, severe infection, and major surgery temporarily lower cholesterol and LDL, so doctors usually retest a few weeks after an acute event for a true baseline.
When to talk to your doctor
- Your LDL is significantly above the lab's reference range, particularly if you have diabetes, hypertension, central obesity, or a family history of early heart disease.
- Your triglycerides are above 500 mg/dL — this level carries a real risk of acute pancreatitis and usually needs prompt treatment.
- Your HDL is persistently low (<40 mg/dL in men or <50 mg/dL in women), especially alongside high triglycerides — this is the classic Asian-Indian dyslipidaemia pattern.
- You are starting or stopping a lipid-lowering medication and the doctor wants to track the effect.
- You have a family history of premature heart attack or stroke (under age 55 in male relatives or under 65 in female relatives) — risk stratification and treatment thresholds shift earlier in this situation.
Related tests
Sources
- Lipid Association of India (LAI) Expert Consensus Statement on Management of Dyslipidaemia — Lipid Association of India
- Cardiological Society of India (CSI) Position Papers — Cardiological Society of India
- Association of Physicians of India (API) Guidelines on Cardiovascular Disease Prevention — Association of Physicians of India
- ACC/AHA Guideline on the Management of Blood Cholesterol — American College of Cardiology / American Heart Association
- ESC/EAS Guidelines on Dyslipidaemias — European Society of Cardiology
See our medical disclaimer for what this content is and is not.